(Q51517678)
Statements
1 reference
A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis. (English)
1 reference
1 reference
Anders Svenningsson
1 reference
Carolina Holmén
1 reference
Fredrik Piehl
1 reference
Jan Hillert
1 reference
Anna Fogdell-Hahn
1 reference
Malin Lundkvist
1 reference
Elin Karlberg
1 reference
Petra Nilsson
1 reference
Charlotte Dahle
1 reference
Nils Feltelius
1 reference
Tomas Olsson
1 reference
12 January 2011
1 reference
17
1 reference
6
1 reference
708-719
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference